首页 | 本学科首页   官方微博 | 高级检索  
     

直肠胃肠间质瘤的临床病理特征和治疗
引用本文:张信华. 直肠胃肠间质瘤的临床病理特征和治疗[J]. 中华结直肠疾病电子杂志, 2019, 8(3): 227-230. DOI: 10.3877/cma.j.issn.2095-3224.2019.03.003
作者姓名:张信华
作者单位:1. 中山大学附属第一医院胃肠外科中心
基金项目:广东省科技计划(No.2016A020213002)
摘    要:直肠是胃肠间质瘤的第三常见部位,其临床病理学特征、生物学行为和解剖部位使其诊治具有特殊性。好发于直肠中下段且术后局部复发率偏高,都是直肠GIST治疗的难点。伊马替尼的围手术期治疗增加了手术切除率并降低了复发率,5 cm以下的直肠GIST靶向治疗联合手术切除治疗效果较好。目前,国内外尚缺少直肠GIST的诊疗规范,未来还需要更多的前瞻性多中心研究进一步探讨并得出结论。

关 键 词:直肠  胃肠间质瘤  伊马替尼  
收稿时间:2018-10-17

Pathoclinical characteristic and treatment of rectal gastrointestinal stromal tumors (GISTs)
Xinhua Zhang. Pathoclinical characteristic and treatment of rectal gastrointestinal stromal tumors (GISTs)[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2019, 8(3): 227-230. DOI: 10.3877/cma.j.issn.2095-3224.2019.03.003
Authors:Xinhua Zhang
Affiliation:1. Department of Gastrointinal Surgery, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
Abstract:Rectum is the third most common site GISTs originise from. The management of rectal GISTs holds characteristics and difficulty owing to biology and anatomical location. They tending to occur in lower rectum with relatively high local recurrence rate. The application of peri-operational imatinib increase the resectability of tumor and lower recurrence rate. For rectal GIST with diameter of less than 5 cm, imatinib combined surgical resection can achieve a good therapeutic effect. At present, there is still lack of standard of diagnosis and treatment for rectal GIST worldwide. More prospective multicenter studies are needed for better understanding and management of this special entity.
Keywords:Rectum  Gastrointestinal stromal tumors  Imatinib  
点击此处可从《中华结直肠疾病电子杂志》浏览原始摘要信息
点击此处可从《中华结直肠疾病电子杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号